The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder: A Systematic Review

By Coghill David  

CNS Drugs, Vol. 24, Iss. 10, 2010-10 ,pp. : 843-866

Adis International

Access to resources Recommend Favorite

Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder

By Kristina Secnik   Andrine Swensen   Maureen J. Lage  

PharmacoEconomics, Vol. 23, Iss. 1, 2005-01 ,pp. : 93-102

Adis International

Access to resources Recommend Favorite

Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder: Current Status of Knowledge

By Huang Yu-Shu   Tsai Ming-Horng  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 539-554

Adis International

Access to resources Recommend Favorite

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

By Peterson Kim   McDonagh Marian   Fu Rongwei  

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics

By Froehlich Tanya E.   McGough James J.   Stein Mark A.  

CNS Drugs, Vol. 24, Iss. 2, 2010-02 ,pp. : 99-117

Adis International

Access to resources Recommend Favorite